Stock listing

Lang & Schwarz:A2QJRU EyePoint, Inc. Aktie

German listing (Lang & Schwarz) of EyePoint, Inc. · home listing NASDAQ:EYPT

Follow EyePoint, Inc. into a list and get an email when it puts out news.

Home listing price · NASDAQ:EYPT

$2.99 USD -0.15 (-4.8%)

Close on Oct 16, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:EYPT

EyePoint, Inc. logo
Ticker
Lang & Schwarz:A2QJRU
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
Lang & Schwarz
Currency
EUR

What changed lately

Calls

Replays

  • Eyepoint (NASDAQ:EYPT) Q1 2026 Earnings Call

    Wed, May 06, 2026 · 8:30 AM ET

    Watch Transcript

  • Eyepoint (NASDAQ:EYPT) Q4 2025 Earnings Call

    Wed, Mar 04, 2026 · 8:30 AM ET

    Watch Transcript

  • Eyepoint (NASDAQ:EYPT) Q3 2025 Earnings Call

    Wed, Nov 05, 2025 · 8:30 AM ET

    Watch Transcript

Latest news

EyePoint Announces Participation at Upcoming Investor Conferences and Scientific Meeting

Sep 2, 2026

EyePoint Reports Second Quarter 2026 Financial Results and Highlights Recent Corporate Developments

Aug 5, 2026

EyePoint Completes Enrollment of Both Pivotal Phase 3 Trials of DURAVYU™ for Treatment of Diabetic Macular Edema (DME)

Jul 30, 2026

EyePoint Appoints Tarek S. Hassan, M.D., as Chief Strategic Science Officer

Jul 13, 2026

EyePoint Announces Third Consecutive Positive DSMC Recommendation for Phase 3 Wet AMD Trials for DURAVYU™, Building Confidence Ahead of Mid-2026 Topline Data

May 14, 2026

EyePoint Reports First Quarter 2026 Financial Results and Highlights Recent Corporate Developments

May 6, 2026

EyePoint to Report First Quarter 2026 Financial Results on May 6, 2026

Apr 29, 2026

EyePoint Reports Fourth Quarter and Full-Year 2025 Financial Results and Highlights Recent Corporate Developments

Mar 4, 2026

EyePoint Announces First Patients Dosed in Both Global Phase 3 Clinical Trials of DURAVYU™ for the Treatment of Diabetic Macular Edema

Mar 2, 2026

EyePoint to Report Fourth Quarter and Full-Year 2025 Financial Results on March 4, 2026

Feb 25, 2026

All EyePoint, Inc. news

Decks

EyePoint, Inc. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
19 in the last 12 months · 179 in all · newest Sep 2, 2026 · oldest 2019
Calls
18 calls with a replay · 18 with a transcript · latest May 6, 2026
Decks
51 decks · latest Sep 10, 2026

Where EyePoint, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:EYPT · Home listingNASDAQUnited StatesUSD
LS Exchange:A2QJRULS ExchangeGermanyEUR
gettex:PV3BgettexGermanyEUR
Lang & Schwarz:A2QJRU · This pageLang & SchwarzGermanyEUR
BOATS:EYPTBOATSUnited StatesUSD
Tradegate:PV3BTradegateGermanyEUR
Dusseldorf:PV3BDusseldorfGermanyEUR
Frankfurt:PV3BFrankfurtGermanyEUR
Munich:PV3BMunichGermanyEUR
Stuttgart:PV3BStuttgartGermanyEUR

Log in to ask 6ix AI your own questions about EyePoint, Inc.